CAS: 542-56-3; Isobutyl Nitrite

该化合物是一种有机化合物,其分子配方为C4H9NO2, 被归类为亚烷酸亚硝酸; 青黄液无色,其特质为果色味; 已知异丁基亚硝酸盐用作血管消毒器,并经常用于医疗领域治疗小行星切除. 此外, 由于其...

结构式图片

欧盟法规

统一分类与标签压力设备指令-第1组危险流体ECHA物质欧盟气雾剂指令-标签制度ECHA物质食品接触材料-禁用CMR物质化妆品禁用物质清单工作场所安全标识要求C&L通报REACH预注册废弃物危险特性清单

上下游产品

CAS号78-83-1 异丁醇 | CAS号513-38-2 碘代异丁烷 | CAS号78-77-3 溴代异丁烷 | CAS号7782-77-6 亚硝酸 | CAS号26397-34-2 isobutyloxyl | CAS号452-62-0 3-溴-4-氟甲苯 | CAS号22288-50-2 4-Hydroxy-alpha... | CAS号78-83-1 异丁醇 | CAS号625-74-1 2-甲-1-硝丙烷 | CAS号78-84-2 异丁醛 | CAS号79-31-2 异丁酸 | CAS号78-81-9 异丁胺 | CAS号110-96-3 二异丁胺 | CAS号78-82-0 异丁腈 | CAS号613-91-2 苯乙酮肟

合成工艺路线路线简述

    Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于alkali Nitrite体系中,化学反应生成 亚硝酸异丁酯
    参考文献:Neogi,Journal Of The Chemical Society,1914,Vol. 105,P. 2375
    标题:Neogi,Journal Of The Chemical Society,1914,Vol. 105,P. 2375

    海关参考信息

    专利信息


    专利号:US-11639349-B2
    优先权日:2020-05-28
    标题:Stereoselective synthesis of intermediate for preparation of heterocyclic compound
    发明人:CHEN WEN-CHANG; HSU HAN-PEI; CHOU SHAN-YEN; CHUANG SHIH-CHIEH; YEN CHI-FENG
    权利人:TAI GEN BIOTECHNOLOGY CO LTD; TAIGEN BIOPHARMACEUTICALS CO BEIJING LTD; TAIGEN BIOTECHNOLOGY CO LTD
    摘要:Provided is a stereoselective synthesis of an intermediate for the preparation of the heterocyclic derivative as a Cap-dependent endonuclease inhibitor. The synthesis process has the advantages of simple operation, higher yield and relatively controllable steroselectivity, such that it is suitable for large-scale production.

    专利号:US-7452994-B2
    优先权日:2001-09-12
    标 题 :Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
    发明人:MCEACHERN ERNEST J; BRIDGER GARY J; SKUPINSKA KRYSTYNA A; SKERLJ RENATO T; YANG WEN
    权利人:ANORMED INC
    摘要:This invention describes various processes for synthesis and resolution of racemic amino-substituted fused bicyclic ring systems. One process utilizes selective hydrogenation of an amino-substituted fused bicyclic aromatic ring system. An alternative process prepares the racemic amino-substituted fused bicyclic ring system via nitrosation. In addition, the present invention describes the enzymatic resolution of a racemic mixture to produce the (R)- and (S)-forms of amino-substituted fused bicyclic rings as well as a racemization process to recycle the unpreferred enantioner. Further provided by this invention is an asymmetric synthesis of the (R)- or (S)-enantiomer of primary amino-substituted fused bicyclic ring systems.

    专利号:US-5180824-A
    优先权日:1990-11-29
    标题 :6-azido-2-fluoropurine, useful in the synthesis of nucleosides
    发明人:BAUMAN JOHN G; WIRSCHING RANDOLPH C
    权利人:BERLEX BIOSCIENCES INC
    摘要:This invention pertains to novel methods of synthesizing fludarabine, fludarabine phosphate and related nucleoside pharmacologic agents utilizing 6-azido-2-fluoropurine as a novel intermediate. n In particular this invention pertains to a synthesis of fludarabine where the relatively low yield fluorination step is done before the costly coupling step.

    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:US-7238814-B2
    优先权日:2000-05-09
    标题:Compositions of S-nitrosothiols and methods of use
    发明人:MAREK PRZEMYSLAW A; TROCHA ANDZREJ M; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K
    权利人:NITROMED INC
    摘要:The invention describes compositions and kits comprising 4-aza-4-(2-methyl-2-sulfanylpropyl) tricyclo(5.2.1.0<2,6>)dec-8-ene-3,5-dione; 4-aza-4-(2-methyl-2-(nitrosothio)propyl) tricyclo(5.2.1.0<2,6>)dec-8-ene-3,5-dione; 4-{1-methyl-1-((2,4,6-trimethoxyphenyl)methylthio)ethyl}-1,3-oxazolidin-2-one; 2-aAmino-3-methyl-3-((2,4,6-trimethoxyphenyl)methylthio)butan-1-ol; 4-(1-methyl-1-(nitrosothio)ethyl)-1,3-oxazolidin-2-one; or pharmaceutically acceptable salts thereof. The compositions of the invention can further comprise at least one penetration enhancer, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one vasoactive agent.

    专利号:US-6133483-A
    优先权日:1998-07-30
    标题 :Process for the production of 2,4,4'-trichloro-2'-methoxydiphenyl ether
    发明人:CLEARY THOMAS F
    摘要:A process is disclosed for the synthesis of 2,4,4'-trichloro-2'-methoxydiphenyl ether, and it's precursor 2,4,4'-trichloro-2'-bromodiphenyl ether, a novel compound.
    江苏贵仁医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.guirenchem.com
    企业联系电话:0519-83489086;13601507568👤
    📞江苏贵仁医药有限公司 ⚠️参考联系方式
    联系人:任经理qq:2402623097
    电话:0519-83489086;13601507568
    手机:13601507568
    传真:qq:2402623097
    邮箱:guiren_medicine@163.com
    通信地址: 江苏省常州市芮城县风陵渡开发区振兴北街北侧
    邮编: 213000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市芮城县风陵渡开发区振兴北街北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏天汁化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tianzhichem.com
    企业联系👤
    📞江苏天汁化学有限公司 ⚠️参考联系方式
    联系人:徐先生

    手机:(0)18906120011
    传真:0519-85066669
    邮箱:xu-863.xu@163.com
    通信地址: 常州新北区魏村江边工业园区
    邮编: 213127
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:常州新北区魏村江边工业园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海亚毓生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yayupharm.com
    企业联系电话:021-54370255👤
    📞上海亚毓生物医药有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:021-54370255
    手机:13862662808
    传真:021-54370255
    邮箱:yayu@yalongchina.net
    通信地址: 上海市金山区金山卫镇秋实路688号
    邮编: 201515
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市金山区金山卫镇秋实路688号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    山东昱轩化工产品有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yuxuanhg.cn
    企业联系电话:18954485533👤
    📞山东昱轩化工产品有限公司 ⚠️参考联系方式
    联系人:杨先生
    电话:18954485533


    邮箱:715547392@QQ.com
    通信地址: 山东省济南市槐荫区
    邮编: 250000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东省济南市槐荫区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Research Communications in Substances Abuse., 3(233), 1982
    摘要:WASON S ET AL; ISOBUTYL NITRITE TOXICITY BY INGESTION; ANN INTERN MED 92(MAY) 637 (1980)
    摘要:COVALLA JR ET AL; SEVERE TRACHEOBRONCHITIS FROM INHALATION OF AN ISOBUTYL NITRITE PREPARATION; DRUG INTELL CLIN PHARM 15(JAN) 51 (1981)
    参考文献:10.1097/00000433-199206000-00007
    摘要:Gowitt GT, Hanzlick RL. Atypical Autoerotic Deaths. The American Journal of Forensic Medicine and Pathology. 1992 Jun;13(2):115–9. doi: 10.1097/00000433-199206000-00007.
    参考文献:10.2165/00002018-199716010-00001
    摘要:Levy M. Role of viral infections in the induction of adverse drug reactions. Drug Saf. 1997 Jan;16(1):1–8. doi: 10.2165/00002018-199716010-00001.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知